1. Home
  2. FUTU vs CYTK Comparison

FUTU vs CYTK Comparison

Compare FUTU & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Futu Holdings Limited

FUTU

Futu Holdings Limited

HOLD

Current Price

$96.62

Market Cap

13.3B

Sector

Finance

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$85.20

Market Cap

10.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FUTU
CYTK
Founded
2011
1997
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.3B
10.7B
IPO Year
2018
2004

Fundamental Metrics

Financial Performance
Metric
FUTU
CYTK
Price
$96.62
$85.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
19
Target Price
$217.75
$89.26
AVG Volume (30 Days)
1.5M
2.4M
Earning Date
05-28-2026
05-05-2026
Dividend Yield
3.39%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$13,368,000.00
Revenue This Year
$27.96
$7.37
Revenue Next Year
$11.89
$310.19
P/E Ratio
$17.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$80.50
$32.89
52 Week High
$202.53
$88.31

Technical Indicators

Market Signals
Indicator
FUTU
CYTK
Relative Strength Index (RSI) 43.76 63.99
Support Level $88.78 $59.07
Resistance Level $103.02 $88.31
Average True Range (ATR) 4.74 2.85
MACD 1.30 0.17
Stochastic Oscillator 38.22 68.03

Price Performance

Historical Comparison
FUTU
CYTK

About FUTU Futu Holdings Limited

Futu Holdings Ltd is an online broker providing one-stop online investing services.. Through its proprietary digital platforms, Futubull and Moomoo, the Company provides a full range of investment services, including trade execution and clearing, margin financing and securities lending, and wealth management. The Group engages in online brokerage services and margin financing services. It generates its revenue in the form of brokerage commission and handling charge services, and interest income. Geographically, it operates in Hong Kong, which derives key revenue and it also has its presence in other countries.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: